4-[5-[[(2-AMINO-2-CARBOXYETHYLSULFANYL)-ETHYL]-(2'-CHLOROETHYL)]-AMINO]-1-METHYL-1H-BENZOIMIDAZOL-2-YL]-BUTANOIC-ACID
Compound with spectra: 1 NMR
![4-[5-[[(2-AMINO-2-CARBOXYETHYLSULFANYL)-ETHYL]-(2'-CHLOROETHYL)]-AMINO]-1-METHYL-1H-BENZOIMIDAZOL-2-YL]-BUTANOIC-ACID](/api/compound/7Aq0gdPmfaF.png?ph=true&h=300&w=458 "4-[5-[[(2-AMINO-2-CARBOXYETHYLSULFANYL)-ETHYL]-(2'-CHLOROETHYL)]-AMINO]-1-METHYL-1H-BENZOIMIDAZOL-2-YL]-BUTANOIC-ACID")
| SpectraBase Compound ID | 7Aq0gdPmfaF |
|---|---|
| InChI | InChI=1S/C19H27ClN4O4S/c1-23-16-6-5-13(11-15(16)22-17(23)3-2-4-18(25)26)24(8-7-20)9-10-29-12-14(21)19(27)28/h5-6,11,14H,2-4,7-10,12,21H2,1H3,(H,25,26)(H,27,28)/t14-/m0/s1 |
| InChIKey | RNESDNSXCCJHDL-AWEZNQCLSA-N |
| Mol Weight | 442.96 g/mol |
| Molecular Formula | C19H27ClN4O4S |
| Exact Mass | 442.144154 g/mol |
| Enantiomer InChIKey | RNESDNSXCCJHDL-CQSZACIVSA-N |
| Racemate InChIKey | RNESDNSXCCJHDL-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|
4-[5-[BIS-[2-(2-AMINO-2-CARBOXYETHYLSULFANYL)-ETHYL]-AMINO]-1-METHYL-1H-BENZOIMIDAZOL-2-YL]-BUTANOIC-ACID
3-pyridinecarboxamide, N-[3-[5-(acetylamino)-1-methyl-1H-benzimidazol-2-yl]propyl]-6-chloro-
2-furancarboxamide, tetrahydro-N-[2-[1-methyl-5-[(2-methyl-1-oxopropyl)amino]-1H-benzimidazol-2-yl]ethyl]-
N-{2-[1-methyl-5-(pentanoylamino)-1H-benzimidazol-2-yl]ethyl}-2-furamide
2-furancarboxamide, tetrahydro-N-[2-[1-methyl-5-[(3-methyl-1-oxobutyl)amino]-1H-benzimidazol-2-yl]ethyl]-
benzamide, N-[2-[5-(acetylamino)-1-methyl-1H-benzimidazol-2-yl]ethyl]-3-chloro-4-fluoro-
2-furancarboxamide, N-[2-[5-(benzoylamino)-1-methyl-1H-benzimidazol-2-yl]ethyl]tetrahydro-
N-{2-[2-(benzoylamino)ethyl]-1-methyl-1H-benzimidazol-5-yl}-4-methylbenzamide
3-pyridinecarboxamide, N-[2-[5-(acetylamino)-1-methyl-1H-benzimidazol-2-yl]ethyl]-6-chloro-
2-furancarboxamide, tetrahydro-N-[2-[1-methyl-5-[[(phenylamino)carbonyl]amino]-1H-benzimidazol-2-yl]ethyl]-
| Title | Journal or Book | Year |
|---|---|---|
| SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA | Drug Metabolism and Disposition | 2005 |